NCCN Presents New Guidelines for Survivorship
The new NCCN Guidelines® for Survivorship were presented at the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™ on March 14, 2013.
FORT WASHINGTON, PA (March 14, 2013)—The National Comprehensive Cancer Network® (NCCN®) has issued its first ever NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship. The new NCCN Guidelines were presented at the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™ by NCCN Guidelines® Panel Chair, Crystal S. Denlinger, MD, Attending Physician and Assistant Professor of Medical Oncology, Fox Chase Cancer Center; as well as NCCN Guidelines Panel Member, Jennifer A. Ligibel, MD, Attending Physician, Adult Oncology, Dana-Farber/Brigham and Women’s Cancer Center, and Assistant Professor, Department of Medicine, Harvard Medical School.
According to the National Cancer Institute (NCI), there are more than 12 million American cancer survivors. Recognizing and managing the health care needs of these survivors has become a significant responsibility of oncologists and primary care providers.
“An individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life,” said Dr. Ligibel. “The NCCN Guidelines for Survivorship focus on the vast and persistent impact both the diagnosis and treatment of cancer have on the adult survivor particularly after they have completed their initial cancer treatment.”
The NCCN Guidelines for Survivorship cover eight distinct areas: anxiety and depression, cognitive function, exercise, fatigue, immunizations and infections, pain, sexual function, and sleep disorders. Key to proper survivorship care, noted Dr. Denlinger, is accurate assessment of survivor’s needs and concerns on a routine basis. The NCCN Guidelines include a sample assessment tool with two to three questions on each of the eight key criteria covered in the guidelines.
For accurate assessment of cognitive function, the NCCN Guidelines for Survivorship recommend obtaining a complete, focused history and consideration of contributing factors, such as medication side effects, hormonal interaction, and distress. These evaluations can lead to important interventions for survivor and/or family education, including, but not limited to, supportive self-management, enhanced organizational strategies, and regular exercise—up to 20 minutes per session of light exercise, one to three days per week.
“Sexual health is an important part of an individual’s overall physical and emotional well-being,” said Dr. Denlinger. The NCCN Guidelines for Survivorship provide physicians with symptom checklists and inventories to assess sexual function in both male and female cancer survivors, and recommend that physicians initiate proactive discussions about sexual function at regular intervals, including topics such as sexual desire, pain, and ability to maintain erection.
Dr. Ligibel spoke about the NCCN Guidelines for Survivorship recommendations for exercise, stating, “Exercise plays a distinct role in post-cancer health. Physical activity should be discussed at every physician visit and survivors should be encouraged to avoid inactivity. Survivors’ exercise recommendations should be tailored to individual ability and preference.”
The NCCN Guidelines for Survivorship recommend that physicians determine survivors’ ability to exercise by attaining a focused history, and assessing factors that impede physical activity, including, but not limited to, physical limitations, social support, environmental factors, pain, fatigue, emotional distress, and comorbidities. The general recommendations for exercise include an overall weekly volume of 75-150 minutes of exercise, depending on intensity, as well as two to three weekly sessions of strength training that include major muscle groups.
The NCCN Guidelines are developed and updated through an evidence-based process in which the expert panels integrate comprehensive clinical and scientific data with the judgment of the multidisciplinary panel members and other experts drawn from NCCN Member Institutions. Access to the complete library of NCCN Guidelines is available free-of-charge to clinicians at NCCN.org.
The full conference agenda is available at NCCN.org. Press inquiries and requests for interview should be addressed to Katie Kiley Brown at firstname.lastname@example.org.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality, effectiveness, and efficiency of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas MD Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.
Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.com.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.